CLINICAL ROLE -
Patent Expirations Expected to Cause Boom in Biosimilars Market
Read More
PADT Appears to Offer No Mortality Benefit to Prostate Cancer Patients
Primary androgen-deprivation therapy appears not to be an effective treatment for men with clinically localized prostate cancer.
NASP Leader Discusses Changing Specialty Pharmacy Landscape
In an interview with Specialty Pharmacy Times, James E. Smeeding, executive director of the National Association of Specialty Pharmacy, discusses the organization's future and issues in the specialty marketplace.
Aspirin Improves Survival in Colon Cancer Patients with Specific Tumor Type
Study finds aspirin improves survival outcomes only for patients with HLA class I antigen expression.
Rapid Growth Predicted for Pancreatic Cancer Treatment Market
Celgene's Abraxane is expected to drive expansion of pancreatic cancer therapeutics market.
Obese Women May Need Higher Dose of IVF Medication
Study suggests that standard dose of GnRH antagonist clears out of obese women's systems more quickly than in normal-weight women.
Cancer, Hepatitis C Drugs Loom Large in Specialty Pipeline
Express Scripts Senior Clinical Consultant Aimee Tharaldson, PharmD, discusses specialty pharmacy treatment options for 2014 and beyond.
Double Dose of Hepatitis B Vaccine Increases Antibody Response in Chronic HCV Patients
Efficacy of standard dose can be suboptimal in patients with hepatitis C, study shows.
Annual NASP EXPO Highlights Latest Trends and Issues for Specialty Pharmacy
National Association of Specialty Pharmacy brings together hundreds of stakeholders to discuss the rapidly changing special medication landscape.
Insurers Surveyed by EMD Serono Identify Challenges, Strategies for Specialty Pharmaceuticals
Complexity of specialty drugs leads most health plans to create specific rules for coverage, cost share, and benefit management, survey indicates.
Serious Liver Disease Persists in HCV Patients with HIV Co-Infection Receiving Antiretroviral Therapy
Patients with co-infection are 80% more likely to have serious liver disease than patients with hepatitis C alone, study finds.
Colorectal Cancer Rate Drops with Increased Testing
Incidence rates decreased 3% per year last decade thanks in part to timely screening tests, report says.
Hy-Vee Expands Footprint with Specialty Pharmacy Acquisition
Hy-Vee's chief health officer says growth of specialty drug market spurred grocery chain to purchase Amber Pharmacy.
Past Exposure to Thiopurines Could Increase Risk of Myeloid Disorders in IBD Patients
Study indicates inflammatory bowel disease treatment needs careful consideration before prescribing.
Multiple Myeloma Precursor Found to Be More Common in African-Americans
Study finds significant racial and geographic disparity in prevalence of monoclonal gammopathy of undetermined significance.
Report Projects Cancer to Be Nation's Leading Cause of Death by 2030
An increase in the number of available anti-cancer drugs will also help lead to more people surviving the disease than ever before.
Integrated Practice Model Can Improve Adherence to Multiple Sclerosis Therapies
Integrated clinical and specialty pharmacy practice model includes an interdisciplinary team of physicians, nurses, and pharmacists.
Gene Therapy Shows Promise in Neutralizing HIV
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.
Hy-Vee Expands Specialty Pharmacy Business
The Midwestern grocery chain has reached agreement to purchase specialty pharmacy solutions provider Amber Pharmacy.
Decrease in HCV Prevalence Could Be Result of Increased Deaths Among Infected
Deaths from chronic hepatitis C virus infection in the United States are grossly underreported, the results of a new study indicate.
Specialty Drug Spending Growth Unsustainable, Report Says
Double-digit annual spending increases for specialty drugs are forecast through 2015, reports America's Health Insurance Plans.
Early Treatment Clears Virus in Second HIV-Infected Baby
A child born infected with HIV in California began treatment hours after birth, and is clear of virus 9 months later.